Global Enasidenib Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Enasidenib market size was valued at US$ 77 million in 2023. With growing demand in downstream market, the Enasidenib is forecast to a readjusted size of US$ 126 million by 2030 with a CAGR of 7.4% during review period.
The research report highlights the growth potential of the global Enasidenib market. Enasidenib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Enasidenib. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Enasidenib market.
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Enasidenib is a targeted therapy used to treat relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. Its efficacy in inhibiting the mutated IDH2 enzyme and inducing remission has driven market growth. The limited treatment options for this specific subset of AML contribute to its niche status. However, challenges include potential side effects and the need for genetic testing to identify eligible patients. The market competition is relatively small, as Enasidenib remains a targeted therapy for a specific AML subgroup. Despite challenges, the Enasidenib market offers potential for growth as healthcare providers seek effective treatments for patients with IDH2-mutated AML. Continued research and clinical advancements can further drive market expansion.
Key Features:
The report on Enasidenib market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Enasidenib market. It may include historical data, market segmentation by Type (e.g., 50mg, 100mg), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Enasidenib market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Enasidenib market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Enasidenib industry. This include advancements in Enasidenib technology, Enasidenib new entrants, Enasidenib new investment, and other innovations that are shaping the future of Enasidenib.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Enasidenib market. It includes factors influencing customer ' purchasing decisions, preferences for Enasidenib product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Enasidenib market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Enasidenib market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Enasidenib market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Enasidenib industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Enasidenib market.
Market Segmentation:
Enasidenib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Enasidenib market?
What factors are driving Enasidenib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enasidenib market opportunities vary by end market size?
How does Enasidenib break out type, application?
According to our LPI (LP Information) latest study, the global Enasidenib market size was valued at US$ 77 million in 2023. With growing demand in downstream market, the Enasidenib is forecast to a readjusted size of US$ 126 million by 2030 with a CAGR of 7.4% during review period.
The research report highlights the growth potential of the global Enasidenib market. Enasidenib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Enasidenib. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Enasidenib market.
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Enasidenib is a targeted therapy used to treat relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. Its efficacy in inhibiting the mutated IDH2 enzyme and inducing remission has driven market growth. The limited treatment options for this specific subset of AML contribute to its niche status. However, challenges include potential side effects and the need for genetic testing to identify eligible patients. The market competition is relatively small, as Enasidenib remains a targeted therapy for a specific AML subgroup. Despite challenges, the Enasidenib market offers potential for growth as healthcare providers seek effective treatments for patients with IDH2-mutated AML. Continued research and clinical advancements can further drive market expansion.
Key Features:
The report on Enasidenib market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Enasidenib market. It may include historical data, market segmentation by Type (e.g., 50mg, 100mg), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Enasidenib market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Enasidenib market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Enasidenib industry. This include advancements in Enasidenib technology, Enasidenib new entrants, Enasidenib new investment, and other innovations that are shaping the future of Enasidenib.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Enasidenib market. It includes factors influencing customer ' purchasing decisions, preferences for Enasidenib product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Enasidenib market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Enasidenib market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Enasidenib market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Enasidenib industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Enasidenib market.
Market Segmentation:
Enasidenib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- 50mg
- 100mg
- Hospital
- Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol Myers Squibb
What is the 10-year outlook for the global Enasidenib market?
What factors are driving Enasidenib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enasidenib market opportunities vary by end market size?
How does Enasidenib break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Enasidenib Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Enasidenib by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Enasidenib by Country/Region, 2019, 2023 & 2030
2.2 Enasidenib Segment by Type
2.2.1 50mg
2.2.2 100mg
2.3 Enasidenib Sales by Type
2.3.1 Global Enasidenib Sales Market Share by Type (2019-2024)
2.3.2 Global Enasidenib Revenue and Market Share by Type (2019-2024)
2.3.3 Global Enasidenib Sale Price by Type (2019-2024)
2.4 Enasidenib Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Enasidenib Sales by Application
2.5.1 Global Enasidenib Sale Market Share by Application (2019-2024)
2.5.2 Global Enasidenib Revenue and Market Share by Application (2019-2024)
2.5.3 Global Enasidenib Sale Price by Application (2019-2024)
3 GLOBAL ENASIDENIB BY COMPANY
3.1 Global Enasidenib Breakdown Data by Company
3.1.1 Global Enasidenib Annual Sales by Company (2019-2024)
3.1.2 Global Enasidenib Sales Market Share by Company (2019-2024)
3.2 Global Enasidenib Annual Revenue by Company (2019-2024)
3.2.1 Global Enasidenib Revenue by Company (2019-2024)
3.2.2 Global Enasidenib Revenue Market Share by Company (2019-2024)
3.3 Global Enasidenib Sale Price by Company
3.4 Key Manufacturers Enasidenib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enasidenib Product Location Distribution
3.4.2 Players Enasidenib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ENASIDENIB BY GEOGRAPHIC REGION
4.1 World Historic Enasidenib Market Size by Geographic Region (2019-2024)
4.1.1 Global Enasidenib Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Enasidenib Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Enasidenib Market Size by Country/Region (2019-2024)
4.2.1 Global Enasidenib Annual Sales by Country/Region (2019-2024)
4.2.2 Global Enasidenib Annual Revenue by Country/Region (2019-2024)
4.3 Americas Enasidenib Sales Growth
4.4 APAC Enasidenib Sales Growth
4.5 Europe Enasidenib Sales Growth
4.6 Middle East & Africa Enasidenib Sales Growth
5 AMERICAS
5.1 Americas Enasidenib Sales by Country
5.1.1 Americas Enasidenib Sales by Country (2019-2024)
5.1.2 Americas Enasidenib Revenue by Country (2019-2024)
5.2 Americas Enasidenib Sales by Type
5.3 Americas Enasidenib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enasidenib Sales by Region
6.1.1 APAC Enasidenib Sales by Region (2019-2024)
6.1.2 APAC Enasidenib Revenue by Region (2019-2024)
6.2 APAC Enasidenib Sales by Type
6.3 APAC Enasidenib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Enasidenib by Country
7.1.1 Europe Enasidenib Sales by Country (2019-2024)
7.1.2 Europe Enasidenib Revenue by Country (2019-2024)
7.2 Europe Enasidenib Sales by Type
7.3 Europe Enasidenib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Enasidenib by Country
8.1.1 Middle East & Africa Enasidenib Sales by Country (2019-2024)
8.1.2 Middle East & Africa Enasidenib Revenue by Country (2019-2024)
8.2 Middle East & Africa Enasidenib Sales by Type
8.3 Middle East & Africa Enasidenib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enasidenib
10.3 Manufacturing Process Analysis of Enasidenib
10.4 Industry Chain Structure of Enasidenib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enasidenib Distributors
11.3 Enasidenib Customer
12 WORLD FORECAST REVIEW FOR ENASIDENIB BY GEOGRAPHIC REGION
12.1 Global Enasidenib Market Size Forecast by Region
12.1.1 Global Enasidenib Forecast by Region (2025-2030)
12.1.2 Global Enasidenib Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Enasidenib Forecast by Type
12.7 Global Enasidenib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bristol Myers Squibb
13.1.1 Bristol Myers Squibb Company Information
13.1.2 Bristol Myers Squibb Enasidenib Product Portfolios and Specifications
13.1.3 Bristol Myers Squibb Enasidenib Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bristol Myers Squibb Main Business Overview
13.1.5 Bristol Myers Squibb Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Enasidenib Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Enasidenib by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Enasidenib by Country/Region, 2019, 2023 & 2030
2.2 Enasidenib Segment by Type
2.2.1 50mg
2.2.2 100mg
2.3 Enasidenib Sales by Type
2.3.1 Global Enasidenib Sales Market Share by Type (2019-2024)
2.3.2 Global Enasidenib Revenue and Market Share by Type (2019-2024)
2.3.3 Global Enasidenib Sale Price by Type (2019-2024)
2.4 Enasidenib Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Enasidenib Sales by Application
2.5.1 Global Enasidenib Sale Market Share by Application (2019-2024)
2.5.2 Global Enasidenib Revenue and Market Share by Application (2019-2024)
2.5.3 Global Enasidenib Sale Price by Application (2019-2024)
3 GLOBAL ENASIDENIB BY COMPANY
3.1 Global Enasidenib Breakdown Data by Company
3.1.1 Global Enasidenib Annual Sales by Company (2019-2024)
3.1.2 Global Enasidenib Sales Market Share by Company (2019-2024)
3.2 Global Enasidenib Annual Revenue by Company (2019-2024)
3.2.1 Global Enasidenib Revenue by Company (2019-2024)
3.2.2 Global Enasidenib Revenue Market Share by Company (2019-2024)
3.3 Global Enasidenib Sale Price by Company
3.4 Key Manufacturers Enasidenib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enasidenib Product Location Distribution
3.4.2 Players Enasidenib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ENASIDENIB BY GEOGRAPHIC REGION
4.1 World Historic Enasidenib Market Size by Geographic Region (2019-2024)
4.1.1 Global Enasidenib Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Enasidenib Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Enasidenib Market Size by Country/Region (2019-2024)
4.2.1 Global Enasidenib Annual Sales by Country/Region (2019-2024)
4.2.2 Global Enasidenib Annual Revenue by Country/Region (2019-2024)
4.3 Americas Enasidenib Sales Growth
4.4 APAC Enasidenib Sales Growth
4.5 Europe Enasidenib Sales Growth
4.6 Middle East & Africa Enasidenib Sales Growth
5 AMERICAS
5.1 Americas Enasidenib Sales by Country
5.1.1 Americas Enasidenib Sales by Country (2019-2024)
5.1.2 Americas Enasidenib Revenue by Country (2019-2024)
5.2 Americas Enasidenib Sales by Type
5.3 Americas Enasidenib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enasidenib Sales by Region
6.1.1 APAC Enasidenib Sales by Region (2019-2024)
6.1.2 APAC Enasidenib Revenue by Region (2019-2024)
6.2 APAC Enasidenib Sales by Type
6.3 APAC Enasidenib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Enasidenib by Country
7.1.1 Europe Enasidenib Sales by Country (2019-2024)
7.1.2 Europe Enasidenib Revenue by Country (2019-2024)
7.2 Europe Enasidenib Sales by Type
7.3 Europe Enasidenib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Enasidenib by Country
8.1.1 Middle East & Africa Enasidenib Sales by Country (2019-2024)
8.1.2 Middle East & Africa Enasidenib Revenue by Country (2019-2024)
8.2 Middle East & Africa Enasidenib Sales by Type
8.3 Middle East & Africa Enasidenib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enasidenib
10.3 Manufacturing Process Analysis of Enasidenib
10.4 Industry Chain Structure of Enasidenib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enasidenib Distributors
11.3 Enasidenib Customer
12 WORLD FORECAST REVIEW FOR ENASIDENIB BY GEOGRAPHIC REGION
12.1 Global Enasidenib Market Size Forecast by Region
12.1.1 Global Enasidenib Forecast by Region (2025-2030)
12.1.2 Global Enasidenib Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Enasidenib Forecast by Type
12.7 Global Enasidenib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bristol Myers Squibb
13.1.1 Bristol Myers Squibb Company Information
13.1.2 Bristol Myers Squibb Enasidenib Product Portfolios and Specifications
13.1.3 Bristol Myers Squibb Enasidenib Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bristol Myers Squibb Main Business Overview
13.1.5 Bristol Myers Squibb Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Enasidenib Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Enasidenib Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 100mg
Table 5. Global Enasidenib Sales by Type (2019-2024) & (Units)
Table 6. Global Enasidenib Sales Market Share by Type (2019-2024)
Table 7. Global Enasidenib Revenue by Type (2019-2024) & ($ million)
Table 8. Global Enasidenib Revenue Market Share by Type (2019-2024)
Table 9. Global Enasidenib Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Enasidenib Sales by Application (2019-2024) & (Units)
Table 11. Global Enasidenib Sales Market Share by Application (2019-2024)
Table 12. Global Enasidenib Revenue by Application (2019-2024)
Table 13. Global Enasidenib Revenue Market Share by Application (2019-2024)
Table 14. Global Enasidenib Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Enasidenib Sales by Company (2019-2024) & (Units)
Table 16. Global Enasidenib Sales Market Share by Company (2019-2024)
Table 17. Global Enasidenib Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Enasidenib Revenue Market Share by Company (2019-2024)
Table 19. Global Enasidenib Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Enasidenib Producing Area Distribution and Sales Area
Table 21. Players Enasidenib Products Offered
Table 22. Enasidenib Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Enasidenib Sales by Geographic Region (2019-2024) & (Units)
Table 26. Global Enasidenib Sales Market Share Geographic Region (2019-2024)
Table 27. Global Enasidenib Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Enasidenib Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Enasidenib Sales by Country/Region (2019-2024) & (Units)
Table 30. Global Enasidenib Sales Market Share by Country/Region (2019-2024)
Table 31. Global Enasidenib Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Enasidenib Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Enasidenib Sales by Country (2019-2024) & (Units)
Table 34. Americas Enasidenib Sales Market Share by Country (2019-2024)
Table 35. Americas Enasidenib Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Enasidenib Revenue Market Share by Country (2019-2024)
Table 37. Americas Enasidenib Sales by Type (2019-2024) & (Units)
Table 38. Americas Enasidenib Sales by Application (2019-2024) & (Units)
Table 39. APAC Enasidenib Sales by Region (2019-2024) & (Units)
Table 40. APAC Enasidenib Sales Market Share by Region (2019-2024)
Table 41. APAC Enasidenib Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Enasidenib Revenue Market Share by Region (2019-2024)
Table 43. APAC Enasidenib Sales by Type (2019-2024) & (Units)
Table 44. APAC Enasidenib Sales by Application (2019-2024) & (Units)
Table 45. Europe Enasidenib Sales by Country (2019-2024) & (Units)
Table 46. Europe Enasidenib Sales Market Share by Country (2019-2024)
Table 47. Europe Enasidenib Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Enasidenib Revenue Market Share by Country (2019-2024)
Table 49. Europe Enasidenib Sales by Type (2019-2024) & (Units)
Table 50. Europe Enasidenib Sales by Application (2019-2024) & (Units)
Table 51. Middle East & Africa Enasidenib Sales by Country (2019-2024) & (Units)
Table 52. Middle East & Africa Enasidenib Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Enasidenib Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Enasidenib Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Enasidenib Sales by Type (2019-2024) & (Units)
Table 56. Middle East & Africa Enasidenib Sales by Application (2019-2024) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Enasidenib
Table 58. Key Market Challenges & Risks of Enasidenib
Table 59. Key Industry Trends of Enasidenib
Table 60. Enasidenib Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Enasidenib Distributors List
Table 63. Enasidenib Customer List
Table 64. Global Enasidenib Sales Forecast by Region (2025-2030) & (Units)
Table 65. Global Enasidenib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Enasidenib Sales Forecast by Country (2025-2030) & (Units)
Table 67. Americas Enasidenib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Enasidenib Sales Forecast by Region (2025-2030) & (Units)
Table 69. APAC Enasidenib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Enasidenib Sales Forecast by Country (2025-2030) & (Units)
Table 71. Europe Enasidenib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Enasidenib Sales Forecast by Country (2025-2030) & (Units)
Table 73. Middle East & Africa Enasidenib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Enasidenib Sales Forecast by Type (2025-2030) & (Units)
Table 75. Global Enasidenib Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Enasidenib Sales Forecast by Application (2025-2030) & (Units)
Table 77. Global Enasidenib Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Bristol Myers Squibb Basic Information, Enasidenib Manufacturing Base, Sales Area and Its Competitors
Table 79. Bristol Myers Squibb Enasidenib Product Portfolios and Specifications
Table 80. Bristol Myers Squibb Enasidenib Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Bristol Myers Squibb Main Business
Table 82. Bristol Myers Squibb Latest Developments
Table 1. Enasidenib Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Enasidenib Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 100mg
Table 5. Global Enasidenib Sales by Type (2019-2024) & (Units)
Table 6. Global Enasidenib Sales Market Share by Type (2019-2024)
Table 7. Global Enasidenib Revenue by Type (2019-2024) & ($ million)
Table 8. Global Enasidenib Revenue Market Share by Type (2019-2024)
Table 9. Global Enasidenib Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Enasidenib Sales by Application (2019-2024) & (Units)
Table 11. Global Enasidenib Sales Market Share by Application (2019-2024)
Table 12. Global Enasidenib Revenue by Application (2019-2024)
Table 13. Global Enasidenib Revenue Market Share by Application (2019-2024)
Table 14. Global Enasidenib Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Enasidenib Sales by Company (2019-2024) & (Units)
Table 16. Global Enasidenib Sales Market Share by Company (2019-2024)
Table 17. Global Enasidenib Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Enasidenib Revenue Market Share by Company (2019-2024)
Table 19. Global Enasidenib Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Enasidenib Producing Area Distribution and Sales Area
Table 21. Players Enasidenib Products Offered
Table 22. Enasidenib Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Enasidenib Sales by Geographic Region (2019-2024) & (Units)
Table 26. Global Enasidenib Sales Market Share Geographic Region (2019-2024)
Table 27. Global Enasidenib Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Enasidenib Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Enasidenib Sales by Country/Region (2019-2024) & (Units)
Table 30. Global Enasidenib Sales Market Share by Country/Region (2019-2024)
Table 31. Global Enasidenib Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Enasidenib Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Enasidenib Sales by Country (2019-2024) & (Units)
Table 34. Americas Enasidenib Sales Market Share by Country (2019-2024)
Table 35. Americas Enasidenib Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Enasidenib Revenue Market Share by Country (2019-2024)
Table 37. Americas Enasidenib Sales by Type (2019-2024) & (Units)
Table 38. Americas Enasidenib Sales by Application (2019-2024) & (Units)
Table 39. APAC Enasidenib Sales by Region (2019-2024) & (Units)
Table 40. APAC Enasidenib Sales Market Share by Region (2019-2024)
Table 41. APAC Enasidenib Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Enasidenib Revenue Market Share by Region (2019-2024)
Table 43. APAC Enasidenib Sales by Type (2019-2024) & (Units)
Table 44. APAC Enasidenib Sales by Application (2019-2024) & (Units)
Table 45. Europe Enasidenib Sales by Country (2019-2024) & (Units)
Table 46. Europe Enasidenib Sales Market Share by Country (2019-2024)
Table 47. Europe Enasidenib Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Enasidenib Revenue Market Share by Country (2019-2024)
Table 49. Europe Enasidenib Sales by Type (2019-2024) & (Units)
Table 50. Europe Enasidenib Sales by Application (2019-2024) & (Units)
Table 51. Middle East & Africa Enasidenib Sales by Country (2019-2024) & (Units)
Table 52. Middle East & Africa Enasidenib Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Enasidenib Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Enasidenib Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Enasidenib Sales by Type (2019-2024) & (Units)
Table 56. Middle East & Africa Enasidenib Sales by Application (2019-2024) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Enasidenib
Table 58. Key Market Challenges & Risks of Enasidenib
Table 59. Key Industry Trends of Enasidenib
Table 60. Enasidenib Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Enasidenib Distributors List
Table 63. Enasidenib Customer List
Table 64. Global Enasidenib Sales Forecast by Region (2025-2030) & (Units)
Table 65. Global Enasidenib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Enasidenib Sales Forecast by Country (2025-2030) & (Units)
Table 67. Americas Enasidenib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Enasidenib Sales Forecast by Region (2025-2030) & (Units)
Table 69. APAC Enasidenib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Enasidenib Sales Forecast by Country (2025-2030) & (Units)
Table 71. Europe Enasidenib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Enasidenib Sales Forecast by Country (2025-2030) & (Units)
Table 73. Middle East & Africa Enasidenib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Enasidenib Sales Forecast by Type (2025-2030) & (Units)
Table 75. Global Enasidenib Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Enasidenib Sales Forecast by Application (2025-2030) & (Units)
Table 77. Global Enasidenib Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Bristol Myers Squibb Basic Information, Enasidenib Manufacturing Base, Sales Area and Its Competitors
Table 79. Bristol Myers Squibb Enasidenib Product Portfolios and Specifications
Table 80. Bristol Myers Squibb Enasidenib Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Bristol Myers Squibb Main Business
Table 82. Bristol Myers Squibb Latest Developments
LIST OF FIGURES
Figure 1. Picture of Enasidenib
Figure 2. Enasidenib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enasidenib Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Enasidenib Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Enasidenib Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 50mg
Figure 10. Product Picture of 100mg
Figure 11. Global Enasidenib Sales Market Share by Type in 2023
Figure 12. Global Enasidenib Revenue Market Share by Type (2019-2024)
Figure 13. Enasidenib Consumed in Hospital
Figure 14. Global Enasidenib Market: Hospital (2019-2024) & (Units)
Figure 15. Enasidenib Consumed in Pharmacy
Figure 16. Global Enasidenib Market: Pharmacy (2019-2024) & (Units)
Figure 17. Global Enasidenib Sales Market Share by Application (2023)
Figure 18. Global Enasidenib Revenue Market Share by Application in 2023
Figure 19. Enasidenib Sales Market by Company in 2023 (Units)
Figure 20. Global Enasidenib Sales Market Share by Company in 2023
Figure 21. Enasidenib Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Enasidenib Revenue Market Share by Company in 2023
Figure 23. Global Enasidenib Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Enasidenib Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Enasidenib Sales 2019-2024 (Units)
Figure 26. Americas Enasidenib Revenue 2019-2024 ($ Millions)
Figure 27. APAC Enasidenib Sales 2019-2024 (Units)
Figure 28. APAC Enasidenib Revenue 2019-2024 ($ Millions)
Figure 29. Europe Enasidenib Sales 2019-2024 (Units)
Figure 30. Europe Enasidenib Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Enasidenib Sales 2019-2024 (Units)
Figure 32. Middle East & Africa Enasidenib Revenue 2019-2024 ($ Millions)
Figure 33. Americas Enasidenib Sales Market Share by Country in 2023
Figure 34. Americas Enasidenib Revenue Market Share by Country in 2023
Figure 35. Americas Enasidenib Sales Market Share by Type (2019-2024)
Figure 36. Americas Enasidenib Sales Market Share by Application (2019-2024)
Figure 37. United States Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Enasidenib Sales Market Share by Region in 2023
Figure 42. APAC Enasidenib Revenue Market Share by Regions in 2023
Figure 43. APAC Enasidenib Sales Market Share by Type (2019-2024)
Figure 44. APAC Enasidenib Sales Market Share by Application (2019-2024)
Figure 45. China Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Enasidenib Sales Market Share by Country in 2023
Figure 53. Europe Enasidenib Revenue Market Share by Country in 2023
Figure 54. Europe Enasidenib Sales Market Share by Type (2019-2024)
Figure 55. Europe Enasidenib Sales Market Share by Application (2019-2024)
Figure 56. Germany Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Enasidenib Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Enasidenib Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Enasidenib Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Enasidenib Sales Market Share by Application (2019-2024)
Figure 65. Egypt Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Enasidenib in 2023
Figure 71. Manufacturing Process Analysis of Enasidenib
Figure 72. Industry Chain Structure of Enasidenib
Figure 73. Channels of Distribution
Figure 74. Global Enasidenib Sales Market Forecast by Region (2025-2030)
Figure 75. Global Enasidenib Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Enasidenib Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Enasidenib Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Enasidenib Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Enasidenib Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Enasidenib
Figure 2. Enasidenib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enasidenib Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Enasidenib Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Enasidenib Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 50mg
Figure 10. Product Picture of 100mg
Figure 11. Global Enasidenib Sales Market Share by Type in 2023
Figure 12. Global Enasidenib Revenue Market Share by Type (2019-2024)
Figure 13. Enasidenib Consumed in Hospital
Figure 14. Global Enasidenib Market: Hospital (2019-2024) & (Units)
Figure 15. Enasidenib Consumed in Pharmacy
Figure 16. Global Enasidenib Market: Pharmacy (2019-2024) & (Units)
Figure 17. Global Enasidenib Sales Market Share by Application (2023)
Figure 18. Global Enasidenib Revenue Market Share by Application in 2023
Figure 19. Enasidenib Sales Market by Company in 2023 (Units)
Figure 20. Global Enasidenib Sales Market Share by Company in 2023
Figure 21. Enasidenib Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Enasidenib Revenue Market Share by Company in 2023
Figure 23. Global Enasidenib Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Enasidenib Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Enasidenib Sales 2019-2024 (Units)
Figure 26. Americas Enasidenib Revenue 2019-2024 ($ Millions)
Figure 27. APAC Enasidenib Sales 2019-2024 (Units)
Figure 28. APAC Enasidenib Revenue 2019-2024 ($ Millions)
Figure 29. Europe Enasidenib Sales 2019-2024 (Units)
Figure 30. Europe Enasidenib Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Enasidenib Sales 2019-2024 (Units)
Figure 32. Middle East & Africa Enasidenib Revenue 2019-2024 ($ Millions)
Figure 33. Americas Enasidenib Sales Market Share by Country in 2023
Figure 34. Americas Enasidenib Revenue Market Share by Country in 2023
Figure 35. Americas Enasidenib Sales Market Share by Type (2019-2024)
Figure 36. Americas Enasidenib Sales Market Share by Application (2019-2024)
Figure 37. United States Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Enasidenib Sales Market Share by Region in 2023
Figure 42. APAC Enasidenib Revenue Market Share by Regions in 2023
Figure 43. APAC Enasidenib Sales Market Share by Type (2019-2024)
Figure 44. APAC Enasidenib Sales Market Share by Application (2019-2024)
Figure 45. China Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Enasidenib Sales Market Share by Country in 2023
Figure 53. Europe Enasidenib Revenue Market Share by Country in 2023
Figure 54. Europe Enasidenib Sales Market Share by Type (2019-2024)
Figure 55. Europe Enasidenib Sales Market Share by Application (2019-2024)
Figure 56. Germany Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Enasidenib Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Enasidenib Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Enasidenib Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Enasidenib Sales Market Share by Application (2019-2024)
Figure 65. Egypt Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Enasidenib Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Enasidenib in 2023
Figure 71. Manufacturing Process Analysis of Enasidenib
Figure 72. Industry Chain Structure of Enasidenib
Figure 73. Channels of Distribution
Figure 74. Global Enasidenib Sales Market Forecast by Region (2025-2030)
Figure 75. Global Enasidenib Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Enasidenib Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Enasidenib Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Enasidenib Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Enasidenib Revenue Market Share Forecast by Application (2025-2030)
